Amanda Hath Guenther, CCC-SLP | |
5606 Shields Dr, Bethesda, MD 20817-3571 | |
(301) 493-0023 | |
(301) 493-8230 |
Full Name | Amanda Hath Guenther |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 5606 Shields Dr, Bethesda, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073748703 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 05815 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Amanda Hath Guenther, CCC-SLP 5606 Shields Dr, Bethesda, MD 20817-3571 Ph: (301) 493-0023 | Amanda Hath Guenther, CCC-SLP 5606 Shields Dr, Bethesda, MD 20817-3571 Ph: (301) 493-0023 |
News Archive
ART Advanced Research Technologies Inc. (ART) (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that Dr. Gregory Czarnota, MD, PhD, Radiation Oncologist at Odette Cancer Centre, Sunnybrook Health Sciences Centre, will be presenting SoftScan® clinical results from a breast cancer treatment monitoring study, at the IEEE Engineering in Medicine and Biology Society 31st Annual International Conference in Minneapolis, Minn.
The same PinnacleHealth team that participated in a three-year clinical trial designed to evaluate potential benefits of a first-of-its-kind drug eluting ABSORB Bioresorbable Vascular Scaffold (BVS), today announced it deployed the device for the first time after FDA approval for commercial use.
A recent pilot study in Brooklyn, New York, with minority students found that exposure to Manga comics (Japanese comic art) promoting fruit intake significantly improved healthy snack selection. As snacking accounts for up to 27% of children's daily caloric intake, and childhood obesity has been linked to inadequate intake of fruits and vegetables, the results of this study could have wide-reaching implications.
Juno Therapeutics, Inc. announced today that the FDA has granted Orphan Drug Designation to its JCAR015 chimeric antigen receptor product candidate. The designation was granted for treatment of acute lymphoblastic leukemia. JCAR015 Phase I trials are currently underway at Juno's collaboration partner, Memorial Sloane Kettering Cancer Center.
› Verified 5 days ago
Natalie Harrell Schneiderman, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4494 North Palmer Road, Bethesda, MD 20889 Phone: 301-295-4864 | |
Elizabeth Thompson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6410 Rockledge Dr, Nrh Regional Rehab - Suite 600, Bethesda, MD 20817 Phone: 301-581-8054 Fax: 301-564-0284 | |
Ms. Denise Karchmer, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9801 Bristol Square Ln, #103, Bethesda, MD 20814 Phone: 858-245-3140 | |
Latha Pothuri, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5606 Shields Dr, Bethesda, MD 20817 Phone: 301-493-0023 | |
Mrs. Janine Marie Segner, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5272 River Rd, Suite 300, Bethesda, MD 20816 Phone: 844-906-7846 | |
Jonathan Choy-yuen, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4860 S Palmer Rd Bldg 51, Bethesda, MD 20889 Phone: 301-319-3710 | |
Swallowing Wellness, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4641 Montgomery Ave Ste 300, Bethesda, MD 20814 Phone: 301-288-1313 |